These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 16092869)
21. Design, synthesis and preliminary biological evaluation of new hydroxamate histone deacetylase inhibitors as potential antileukemic agents. Guandalini L; Cellai C; Laurenzana A; Scapecchi S; Paoletti F; Romanelli MN Bioorg Med Chem Lett; 2008 Sep; 18(18):5071-4. PubMed ID: 18723349 [TBL] [Abstract][Full Text] [Related]
22. Solid-phase synthesis of di- and tripeptidic hydroxamic acids as inhibitors of procollagen C-proteinase. Dankwardt SM; Billedeau RJ; Lawley LK; Abbot SC; Martin RL; Chan CS; Van Wart HE; Walker KA Bioorg Med Chem Lett; 2000 Nov; 10(22):2513-6. PubMed ID: 11086718 [TBL] [Abstract][Full Text] [Related]
23. The combined solid/solution-phase synthesis of nitrosamines: the evolution of the "libraries from libraries" concept. Yu Y; Ostresh JM; Houghten RA J Org Chem; 2003 Jan; 68(1):183-6. PubMed ID: 12515480 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group. Chen PC; Patil V; Guerrant W; Green P; Oyelere AK Bioorg Med Chem; 2008 May; 16(9):4839-53. PubMed ID: 18397827 [TBL] [Abstract][Full Text] [Related]
26. A hydroxamic-acid-containing nucleoside inhibits DNA repair nuclease SNM1A. Doherty W; Dürr EM; Baddock HT; Lee SY; McHugh PJ; Brown T; Senge MO; Scanlan EM; McGouran JF Org Biomol Chem; 2019 Sep; 17(35):8094-8105. PubMed ID: 31380542 [TBL] [Abstract][Full Text] [Related]
27. O-aryloxycarbonyl hydroxamates: new beta-lactamase inhibitors that cross-link the active site. Wyrembak PN; Babaoglu K; Pelto RB; Shoichet BK; Pratt RF J Am Chem Soc; 2007 Aug; 129(31):9548-9. PubMed ID: 17628063 [No Abstract] [Full Text] [Related]
28. Natural products in parallel chemistry--novel 5-lipoxygenase inhibitors from BIOS-based libraries starting from alpha-santonin. Schwarz O; Jakupovic S; Ambrosi HD; Haustedt LO; Mang C; Müller-Kuhrt L J Comb Chem; 2007; 9(6):1104-13. PubMed ID: 17850107 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and structure-activity relationships of 3-phenyl-2-propenamides as inhibitors of glycogen phosphorylase a. Li YH; Coppo FT; Evans KA; Graybill TL; Patel M; Gale J; Li H; Tavares F; Thomson SA Bioorg Med Chem Lett; 2006 Nov; 16(22):5892-6. PubMed ID: 16942879 [TBL] [Abstract][Full Text] [Related]
30. Stereoselective synthesis of cis-1,3-disubstituted cyclobutyl kinase inhibitors. Helal CJ; Kang Z; Lucas JC; Bohall BR Org Lett; 2004 May; 6(11):1853-6. PubMed ID: 15151431 [TBL] [Abstract][Full Text] [Related]
31. Design and synthesis of novel metalloproteinase inhibitors. Nakatani S; Ikura M; Yamamoto S; Nishita Y; Itadani S; Habashita H; Sugiura T; Ogawa K; Ohno H; Takahashi K; Nakai H; Toda M Bioorg Med Chem; 2006 Aug; 14(15):5402-22. PubMed ID: 16621578 [TBL] [Abstract][Full Text] [Related]
32. A highly efficient, asymmetric synthesis of benzothiadiazine-substituted tetramic acids: potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase. Fitch DM; Evans KA; Chai D; Duffy KJ Org Lett; 2005 Nov; 7(24):5521-4. PubMed ID: 16288546 [TBL] [Abstract][Full Text] [Related]
33. Structure-activity relationship studies of novel oxygen-incorporated SAHA analogues. Kim SA; Jin YL; Kim HS Arch Pharm Res; 2009 Jan; 32(1):15-21. PubMed ID: 19183872 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and cancer antiproliferative activity of new histone deacetylase inhibitors: hydrophilic hydroxamates and 2-aminobenzamide-containing derivatives. Nagaoka Y; Maeda T; Kawai Y; Nakashima D; Oikawa T; Shimoke K; Ikeuchi T; Kuwajima H; Uesato S Eur J Med Chem; 2006 Jun; 41(6):697-708. PubMed ID: 16584813 [TBL] [Abstract][Full Text] [Related]
36. Inhibitors of the FEZ-1 metallo-beta-lactamase. Liénard BM; Horsfall LE; Galleni M; Frère JM; Schofield CJ Bioorg Med Chem Lett; 2007 Feb; 17(4):964-8. PubMed ID: 17157014 [TBL] [Abstract][Full Text] [Related]
37. Class II-selective histone deacetylase inhibitors. Part 2: alignment-independent GRIND 3-D QSAR, homology and docking studies. Ragno R; Simeoni S; Rotili D; Caroli A; Botta G; Brosch G; Massa S; Mai A Eur J Med Chem; 2008 Mar; 43(3):621-32. PubMed ID: 17698257 [TBL] [Abstract][Full Text] [Related]
38. Synthesis of 1-D-6-O-[2-(N-hydroxyaminocarbonyl)amino-2-deoxy-alpha-D-glucopyranosyl]-myo-inositol 1-(n-octadecyl phosphate): a potential metalloenzyme inhibitor of glycosylphosphatidylinositol biosynthesis. Crossman AT; Urbaniak MD; Ferguson MA Carbohydr Res; 2008 Jul; 343(9):1478-81. PubMed ID: 18479678 [TBL] [Abstract][Full Text] [Related]
39. Solid phase combinatorial synthesis of benzothiazoles and evaluation of topoisomerase II inhibitory activity. Choi SJ; Park HJ; Lee SK; Kim SW; Han G; Choo HY Bioorg Med Chem; 2006 Feb; 14(4):1229-35. PubMed ID: 16242334 [TBL] [Abstract][Full Text] [Related]
40. Solid-phase synthesis of oligoester ion channels. Fyles TM; Hu CW; Luong H J Org Chem; 2006 Oct; 71(22):8545-51. PubMed ID: 17064032 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]